IDEX IDEX Biometrics ASA

IDEX has successfully completed a private placement of shares, raising NOK 90 million (USD 10 million)

IDEX has successfully completed a private placement of shares, raising NOK 90 million (USD 10 million)

Oslo, Norway, 18 November 2019:  IDEX Biometrics ASA, a leading provider of advanced fingerprint identification and authentication solutions, has successfully obtained subscription for 120 million new shares at NOK 0.75 per share, raising NOK 90.0 million (USD 9.9 million).

This fundraising will meet the company’s capital requirements and the board expects, based on current market conditions, that these funds will take the company through to profitability.

The new shares were placed to eight shareholders about 1 % below the closing price at Oslo Børs on 15 November 2019. The board believes that the private placement is an appropriate funding mechanism at the current time and is in the best interest of the company and all of its shareholders. The board considers it is appropriate to waive the existing shareholders’ preferential right to subscribe for new shares because the placement secures timely financing for the company while balancing shareholders’ dilution and risk.

The placement is divided into two tranches. Tranche one, consisting of 55.4 million shares, will be issued as soon as practical under the board’s current authorization to issue shares in private placements. The second tranche, consisting of 64.6 million shares, will be issued subject to approval by an extraordinary general meeting. The board has resolved to call an extraordinary general meeting to be held on or around 12 December 2019. A notice of the extraordinary general meeting will be issued in due course. The company will issue a listing prospectus in connection with tranche two.

Following the tranche one capital increase, IDEX will have a share capital amounting to NOK 98,012,120.85 divided into 653,414,139 shares at NOK 0.15 nominal value per share. Following the tranche two capital increase, IDEX will have a share capital amounting to NOK 107,698,309.80 divided into 717,988,732 shares at NOK 0.15 nominal value per share.

The company’s strategy to be a leader in delivering fingerprint solutions to mass markets is based on a unique flexible and cost efficient off‐chip technology. Recent milestones achieved by the company highlight the tangible progress the company has made and validates the growing demand for biometric solutions. In the biometric payment card market, the company’s largest potential revenue opportunity, there are positive developments in manufacturing and certification, while the company’s remote enroll solution has the potential to become the industry standard. In the access control market, the company is seeing the beginning of shipments and design-in wins and the company expects that both markets will see volume shipments in 2020.

Stan Swearingen, CEO of IDEX said: “We are delighted to secure this funding from existing shareholders. This funding will secure necessary capital to meet the impending market growth and large-scale commercialization of biometric smart cards, and enable IDEX to be a leader in the large and growing biometric smart card market. This investment is a strong endorsement of the significant value-creation potential of IDEX’s fingerprint biometric technology for its customers, partners, and shareholders.”

For further information contact:

Derek P. D’Antilio, CPA;

Chief Financial Officer

Tel: +1 978 273 1344

derek.d’

Erling Svela

VP Finance

Tel:

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all.  We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit and follow @IDEXBiometrics



This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

EN
18/11/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX Biometrics ASA

 PRESS RELEASE

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - ...

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - 9 Jan 2024 Issuer name: IDEX Biometrics ASA Ex. date: 9 January 2024 Type of corporate action: Share consolidation (reverse split) Previous ISIN: NO0003070609 New ISIN: NO0013107490 For further information contact:Marianne Bøe, Investor RelationsE-mail: Tel: About this noticeThis notice was published by Erling Svela, Vice president of finance, on 9 January 2024 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to Continuing Obligations at Oslo Børs Euronext and is published ...

 PRESS RELEASE

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024 Utstedernavn: Idex Biometrics ASA Ex. Dato: 9. januar 2024 Type selskapshandling: Aksjespleis Tidligere ISIN: NO0003070609 Ny ISIN: NO0013107490 For ytterligere informasjon kontact:Marianne Bøe, investorkontaktE-mail: Tel: Om denne meldingenDenne meldingen ble publisert av økonomisjef Erling Svela den 9. januar 2024 kl 08:00 CET på vegne av IDEX Biometrics ASA. Informasjonen skal offentligjøres iht løpende forpliktelser ved Oslo Børs Euronext og utsendes i tråd med paragraf 5‑12 i verdipapirhandelloven.

 PRESS RELEASE

Registration of share consolidation (reverse split) in IDEX Biometrics...

Registration of share consolidation (reverse split) in IDEX Biometrics - 8 Jan 2024 Reference is made to the notice on 21 December 2023 about the five-to-one share consolidation (reverse split) resolved by the extraordinary general meeting on the same day, agenda item 3. The consolidation has been registered. Following the registration, the company's share capital remains NOK 209,551,597.50, but is now divided into 279,402,130 shares, each with a nominal value of NOK 0.75. For the avoidance of doubt, the registration does not affect the dates set forth in the notice of key informatio...

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 29 Dec 2023

Registration of share capital increase in IDEX Biometrics 29 Dec 2023 Reference is made to the notice on 22 December 2023 regarding issue of two shares  at NOK 0.15 per shareto an employee of the company as part of the five-to-one share consolidation resolved by the extraordinary general meeting on 21 December 2023, agenda item 3. The consolidation of shares will take place on or about 10 January 2024. Reference is made to the notice of the extraordinary general meeting issued on 30 November 2023 and the notice of resolutions made by the extraordinary general meeting issued on 21 December 2...

 PRESS RELEASE

IDEX Biometrics convertible loan agreement completed 28 Dec 2023

IDEX Biometrics convertible loan agreement completed 28 Dec 2023 Reference is made to the notice by IDEX Biometrics ASA on 26 December 2023 that the convertible loan agreement had been entered into. All closing conditions have now been met and satisfied and closing of the convertible bond transaction has been completed. The initial conversion price, NOK 0.7330 per share, was correctly stated in the notice, but the calculation basis should have been phrased as follows: “The initial conversion price will be NOK 0.7330 per share, which is 125% of the lowest volume weighted average price (VWAP...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch